UNSPSC 51162041: Beclometasone dipropionate/formoterol fumarate

Beclometasone dipropionate/formoterol fumarate is an inhalable fixed-dose combination drug used to treat chronic obstructive pulmonary disease and asthma.

UNSPSC 51162041 Beclomethasone dipropionate/formoterol fumarate is a Commodity code representing a specific pharmaceutical combination product used in respiratory and emergency medical care. State and local governments purchase this medication and related pharmaceuticals through multiple procurement channels — direct purchase orders, cooperative purchasing agreements, and master supply agreements with healthcare systems, fire departments, emergency medical services, and public health clinics. The medication appears in solicitations alongside broader pharmaceutical and medical supply procurement rather than as a standalone line item, typically bundled within larger EMS, wellness, or clinical pharmacy acquisitions. Issuing bodies include county health departments, municipal fire and EMS agencies, county and municipal healthcare clinics, and multistate cooperative purchasing organizations; the Seminole County, Florida community health system and the City of Tucson Fire Department represent typical recent buyers. Geographic activity spans Florida, Arizona, Minnesota, and other states participating in cooperative purchasing alliances like MMCAP, reflecting broad distribution across regions with active emergency medical and public health infrastructure.

Recent solicitations show the code's practical application within larger pharmaceutical and medical supply frameworks. Seminole County procured 1,900 units of naloxone and drug deactivation systems annually through IFB 60459723LAS (response deadline July 26, 2023), with quarterly deliveries to the county's Community Health Building in Sanford. The City of Tucson Fire Department issued RFP 260217 on June 24, 2026, seeking BLS and ALS pharmaceuticals, supplies, and vending systems — a 251-line-item procurement including medications, diagnostic equipment, and inventory management software, with federal compliance obligations (ARPA, HUD, FTA funding) and strict requirements for pharmacy licensure, DEA compliance, and 95 percent fill rates. Minnesota's MMCAP cooperative issued an RFP for generic multi-source pharmaceuticals and OTC products (S1070000015802, due March 26, 2026) to serve multiple state and local facilities across jurisdictions including Oregon, with authorized wholesaler distribution channels and a July 1, 2026, effective date. These solicitations confirm active demand for pharmaceutical sourcing among municipal and county health systems, with emphasis on regulatory compliance, reliable supply chains, and integration with existing inventory management platforms.